CanniMed Therapeutics Inc (TSX:CMED; OTC:CMMDF)
CanniMed has traded for roughly 4 months now and has seemingly never gotten too much love from the markets. One reason I’ve seen presented by many folks in the industry is that their share price is not designed for the ‘retail investor’. I happen to agree with this take for the most part and it is further exacerbated by the fact that they have very tight float (outstanding shares) compared to other companies in the industry. From a fundamental perspective the less love they get from the market the more of a value they become in my opinion. As a “trader” stock the lack of outstanding shares can make it tough for you to get in and out of positions. Having said all that, CanniMed is above historical support around $11 and is a very interesting company for the ‘value investor’ in this writer’s opinion.
118